David Grayzel is a Partner at Atlas Venture, where he invests in Seed, Early Stage, Series A–C, and Post-IPO Equity opportunities across biotechnology, health care, pharmaceuticals, and therapeutics. He focuses on companies in the United States, particularly the Northeastern US, New England, Massachusetts, and the Greater Boston Area. Atlas Venture raised a fund in October 2021. He has invested in companies like Day One Biopharmaceuticals, Vigil Neuroscience, HotSpot Therapeutics, Q32 Bio, and Xilio Therapeutics. Before Atlas Venture, he was Managing Director at Atlas Venture Development Corp., VP Clinical Development and Medical Affairs at Infinity Pharmaceuticals, Director of Corporate Development and Business Operations at Dyax Corp, and an Intern/Resident at Massachusetts General Hospital. David graduated from Harvard Medical School and lives in Cambridge, Massachusetts, United States.
David Grayzel, Partner @ Atlas. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for David Grayzel from Atlas Venture. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to David
Map your path to David instantly
Connect your network and Draftboard will automatically find and score the strongest paths to David
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.